ArticleScientific reports2016

Prognostic risk model development and prospective validation among patients with cervical cancer stage IB2 to IIB submitted to neoadjuvant chemotherapy.

Kecheng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.